Primary central nervous system lymphoma (PCNSL) is a type of central nervous system
restricted non-Hodgkin lymphoma, whose histopathological diagnosis is majorly large B cell …

Targeted therapy with Bruton tyrosine kinase (BTK) inhibitors have revolutionized the
treatment of patients with various B-cell malignancies. BTK inhibitors such as ibrutinib …

Waldenström macroglobulinemia (WM) is a rare form of non-Hodgkin B-cell lymphoma with
a variable clinical presentation that can impact a patient's quality of life by causing anemia …

Despite significant improvements in prognosis, a subset of patients with primary central
nervous system lymphoma (PCNSL) remains at high risk for relapse. The treatment of …

Current therapeutic strategies for central nervous system (CNS) relapse of diffuse large B-
cell lymphoma (DLBCL) are extremely limited. Secondary central nervous system lymphoma …

Primary central nervous system lymphoma (PCNSL) is a rare and highly aggressive
extranodal type of non-Hodgkin lymphoma. After the introduction and widespread use of …

Lymphoma occurring in the central nervous system is considered primary central nervous
system lymphoma (PCNSL), usually without systematic lesions. Over the last few decades, a …

This is a case of hemophagocytic intravascular large B-cell lymphoma (IVLBCL) with central
nervous system (CNS) involvement. Although R-CHOP chemotherapy regimen has been …

Waldenström macroglobulinemia (WM) is a slowly progressing B-cell non-Hodgkin
lymphoma characterized by monoclonal IgM gammopathy in the blood and infiltration of the …

Introduction: Primary central nervous system lymphoma (PCNSL) is a rare subtype of
aggressive extranodal non-Hodgkin lymphoma. Currently, there is no standard of care for …